HORIZONS GLOBAL SOLUTIONS LLC

Lobbying for CAPTURA BIOPHARMA · Captura is developing an orally administered MCM for radionuclide contamination.

Filing 4th Quarter - Amendment

4th Quarter (Oct 1 - Dec 31) 2025 · Arkansas · House · Senate · posted Feb 10, 2026

Lobbying activity 2

Defense

2026/2027 NDAA; FY2026/2027 Defense Appropriations

Disaster Planning/Emergencies

FY2026/2027 NDAA; FY2026/2027 Defense Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.